Global Cardiovascular Drugs Market Growth 2023-2029

Global Cardiovascular Drugs Market Growth 2023-2029

Cardiovascular Drugs and Therapy is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to cardiology. It was established in 1987 and is published by Springer Science+Business Media on behalf of the International Society of Cardiovascular Pharmacotherapy, of which it is the official journal. The editors-in-chief are Willem J. Remme (Carol Davila University of Medicine and Pharmacy) and Robert S. Rosenson (Icahn School of Medicine at Mount Sinai).

LPI (LP Information)' newest research report, the “Cardiovascular Drugs Industry Forecast” looks at past sales and reviews total world Cardiovascular Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Drugs sales for 2023 through 2029. With Cardiovascular Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Drugs industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiovascular Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Drugs.

The global Cardiovascular Drugs market size is projected to grow from US$ 5884.1 million in 2022 to US$ 6231.7 million in 2029; it is expected to grow at a CAGR of 6231.7 from 2023 to 2029.

Geographically, North America captured lion’s share of global cardiovascular drugs market in 2016. However increasing adoption of generics in the U.S. is key concern area among key players. Asia Pacific market is projected to gain market share during the forecast period and is likely to be key revenue generator in the coming years. Initiatives by local governments to attain self-sufficiency in manufacturing pharmaceuticals and incentives for generic production in countries such as Brazil, South Africa, Saudi Arabia, etc. is likely to boost market growth in Latin America and Middle East & Africa.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Renin-Angiotensin System Blockers
Beta Blockers
Diuretics
Anti-Clotting Agents
Antihyperlipidemic

Segmentation by application
Hypertension
Hyperlipidemia

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
AstraZeneca
Bayer
Bristol Myers Squibb and Pfizer
Daiichi Sankyo
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Portola
Sanofi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiovascular Drugs market?

What factors are driving Cardiovascular Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiovascular Drugs market opportunities vary by end market size?

How does Cardiovascular Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.